✦ LIBER ✦

Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CORRIGENDUM: Dapagliflozin, a Novel, Sel

📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Lessons from trials in hypertensive type

✍ Luis M. Ruilope 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 371 KB

Dapagliflozin: a sodium glucose cotransp

✍ Abd A. Tahrani; Anthony H. Barnett 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 879 KB

Coronary disease, dyslipidaemia and clin

✍ Watts, Gerald F. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Mastering a mediator: blockade of CCN-2

✍ Stephen M. Twigg 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 151 KB

Experience-based group education in Type

✍ Anna Sarkadi; Urban Rosenqvist 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 115 KB